Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
Acer Therapeutics Inc. (ACER) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/27/2023 8-K Quarterly results
01/05/2023 8-K Investor presentation
Docs: "Acer Therapeutics Inc. Corporate Presentation, January 2023",
"Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 in Men with Adenocarcinoma of the Prostate POSH-MAP and PORT-MAP investigator-sponsored trials to evaluate ability of ACER-801 to reduce hot flashes and as neoadjuvant therapy in men with prostate cancer"
01/03/2023 8-K Investor presentation
Docs: "Extension Agreement, among Acer Therapeutics Inc., MAM Aardvark, LLC as administrative and collateral agent for the lenders, and the lenders party thereto",
"Acer Therapeutics Inc. Corporate Presentation, January 2023"
08/23/2022 8-K Investor presentation
Docs: "Acer Therapeutics Inc. Corporate Presentation, August 23, 2022"
08/15/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
03/16/2022 8-K Investor presentation
Docs: "Acer Therapeutics Inc. Corporate Presentation, March 16, 2022"
10/14/2021 8-K Investor presentation
Docs: "Acer Therapeutics Inc. Corporate Presentation, October 14, 2021"
06/17/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
04/02/2021 8-K Quarterly results
03/01/2021 8-K Quarterly results
01/15/2021 8-K Quarterly results
11/10/2020 8-K Investor presentation, Quarterly results
Docs: "Acer Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update",
"Acer Therapeutics Inc. Corporate Presentation, November 2020"
09/01/2020 8-K Quarterly results
08/13/2020 8-K Quarterly results
07/14/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
03/18/2020 8-K Investor presentation, Quarterly results
Docs: "Pillsbury Winthrop Shaw Pittman LLP",
"Acer Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update OND denies Acer’s appeal but describes possible paths forward for EDSIVO&#8482",
"Acer Therapeutics Inc. Corporate Presentation, March 2020",
"Acer Receives Formal Dispute Resolution Request Response from FDA’s Office of New Drugs Office of New Drugs denies Acer’s appeal but describes possible paths forward for EDSIVO&#8482"
02/24/2020 8-K Quarterly results
01/02/2020 8-K Quarterly results
10/28/2019 8-K Investor presentation
Docs: "Acer Therapeutics Inc. Corporate Presentation, October 2019",
"Acer Therapeutics Announces Full Enrollment of Part A in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders Results Expected in Q1 2020 with a Planned NDA Submission in Q1 2021"
08/13/2019 8-K Investor presentation, Quarterly results
Docs: "Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update",
"Acer Therapeutics Inc. Investor Presentation, August 2019"
04/05/2019 8-K Investor presentation
Docs: "Acer Therapeutics Inc. Investor Presentation, April 2019"
01/07/2019 8-K Investor presentation
Docs: "Acer Therapeutics Inc. Investor Presentation, January 2019"
06/29/2018 8-K Investor presentation
Docs: "Acer Therapeutics Inc. Investor Presentation, July 2018"
09/12/2016 8-K Investor presentation
09/02/2015 8-K Investor presentation
Docs: "Opexa Therapeutics, Inc. Investor Presentation, September 2015"
05/14/2014 8-K Investor presentation, Quarterly results
Docs: "Opexa Therapeutics Reports First Quarter 2014 Financial Results and Provides Corporate Update",
"Opexa Therapeutics, Inc. Earnings Update Teleconference Presentation"
02/27/2014 8-K Investor presentation
Docs: "Opexa Therapeutics, Inc. Earnings Update Teleconference Presentation"
11/07/2013 8-K Form 8-K - Current report
08/14/2013 8-K Form 8-K - Current report
05/14/2013 8-K Investor presentation, Quarterly results
Docs: "Opexa Therapeutics Reports First Quarter 2013 Financial Results and Provides Corporate Update",
"Opexa Therapeutics, Inc. Earnings Update Teleconference Presentation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy